Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 122 Published: March 30, 2022 Report Code: GDME1324EPD

An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm. EP ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. Standard and advanced ablation catheters are tracked under this segment.

The electrophysiology ablation catheters pipeline market report provides comprehensive information about the electrophysiology ablation catheters pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The electrophysiology ablation catheters pipeline report provides detailed insights into the pipeline products by a regulatory path including PMA, 510(k), CE, NMPA, TGA, Shonin, MDCO, and Ninsho. As per this report, more than 6 clinical trials are currently ongoing and recruiting, over 4 clinical trials are ongoing but not recruiting, and only 1 clinical trial is planned.

What stage of development outlook of the electrophysiology ablation catheters pipeline products market?

As of March 2022, more than 4 pipeline products are in the early development stage and over 30 pipeline products are in the inactive stage. Apart from this, more than 15 pipeline products are in the clinical stage, 4 products are in the pre-clinical stage and over 5 products are in the approval process.

What are the key segments in the electrophysiology ablation catheters pipeline products market?

The key segments in the electrophysiology ablation catheters pipeline products markets are irrigated tip RF ablation catheters, conventional radio frequency ablation catheters, cryoablation catheters, advanced ablation catheters, laser ablation catheters, and standard ablation catheters.

Electrophysiology ablation catheters pipeline products market, by segments

Electrophysiology ablation catheters pipeline products market, by segmentsFor more segment insights, download a free report sample

Which are the key territories in the electrophysiology ablation catheters pipeline products market?

The US is the leading territory in the electrophysiology ablation catheters pipeline products market followed by China, Europe, Israel, Australia, Japan, Macau, New Zealand, and Hong Kong.

Electrophysiology ablation catheters pipeline products market, by territories

Electrophysiology ablation catheters pipeline products market, by territories

For more territory insights, download a free report sample

Which are the key companies in the electrophysiology ablation catheters pipeline products market?

The key companies in the electrophysiology ablation catheters pipeline products market are Ablacon Inc, Acotec Scientific Co Ltd, Apama Medical Inc, APT Medical Inc, Biosense Webster Inc, BioTex Inc, Boston Scientific Corp, CardioFocus Inc, CardioNova Ltd, CathEffects LLC, CathRx Ltd, Cibiem Inc., Columbia University, Cordis Corp, and CoreMap Inc.

Ablacon Inc

Ablacon Inc offers AI-based atrial fibrillation therapies that visualize the electrographic flow and monitor the heart in real-time to understand and treat atrial fibrillation (AF) qualitatively and quantitatively.

Apama Medical Inc

Apama Medical Inc (Apama Medical) is a medical device company that provides innovative solutions and addresses unmet clinical needs in the underpenetrated and rapidly growing atrial fibrillation (AF) market. The company is headquartered in Campbell, California, the US.

Biosense Webster Inc

Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures, and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters & access, ultrasound catheters, and 3D cardiac mapping. It also offers fibrillation, ventricular tachycardia, atrial flutter, simple arrhythmias, and fluoro reduction solutions. Biosense Webster provides onsite training, offsite workshops, online training, EP training, and professional and medical education services. The company offers training and online courses through its education centers in the US, Germany, Belgium, Sweden, and Spain. Biosense Webster is headquartered in Diamond Bar, California, the US.

Electrophysiology ablation catheters pipeline products market, by companies

Electrophysiology ablation catheters pipeline products market, by companies

To know more about key companies, download a free report sample

Market report scope

Key territories The US, China, Europe, Israel, Australia, Japan, Macau, New Zealand, and Hong Kong
Key segments Irrigated Tip RF Ablation Catheters, Conventional Radio Frequency Ablation Catheters, Cryoablation Catheters, Advanced Ablation Catheters, Laser Ablation Catheters, and Standard Ablation Catheters
Key companies Ablacon Inc, Acotec Scientific Co Ltd, Apama Medical Inc, APT Medical Inc, Biosense Webster Inc, BioTex Inc, Boston Scientific Corp, CardioFocus Inc, CardioNova Ltd, CathEffects LLC, CathRx Ltd, Cibiem Inc., Columbia University, Cordis Corp, and CoreMap Inc

 Scope

  • Extensive coverage of the electrophysiology ablation catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of electrophysiology ablation catheters and lists all their pipeline projects
  • The coverage of pipeline products is based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Identify and understand important and diverse types of electrophysiology ablation catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Key Players

Ablacon Inc
Acotec Scientific Co Ltd
Apama Medical Inc
Biosense Webster Inc
BioTex Inc
Boston Scientific Corp
CardioFocus Inc
CardioNova Ltd
CathEffects LLC
CathRx Ltd
Cibiem Inc
Columbia University
Cordis Corp
CoreMap Inc
CPSI Biotech
CryoTherapeutics Gmbh
Epicardial Technologies Inc (Inactive)
Ethicon US LLC
Eximo Medical Ltd
FocusStart LLC
Hansen Medical Inc (Inactive)
Hyblate Medical
Imricor Medical Systems Inc
Interventional Imaging, Inc.
Iowa Approach Inc.
Maestro Heart SA
Medlumics SL
Medtronic Plc
MedWaves Inc
MicroPort Scientific Corp
Northwestern University
Novasentis Inc
S4 Medical Corp
SCR, Inc.
Seattle Children's Hospital
Shanghai HeartCare Medical Technology Co Ltd
Shanghai MicroPort EP MedTech Co Ltd
St. Jude Medical LLC
Stereotaxis Inc
University of Arkansas at Little Rock
University of Michigan
University of Rochester
University of Texas Medical Branch at Galveston
Vanderbilt University
Vimecon GmbH
Vivonics Inc
Voyage Medical (Inactive)
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 10

2 Introduction 11

2.1 Electrophysiology Ablation Catheters Overview 11

3 Products under Development 12

3.1 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 12

3.2 Electrophysiology Ablation Catheters – Pipeline Products by Segment 13

3.3 Electrophysiology Ablation Catheters – Pipeline Products by Territory 14

3.4 Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 15

3.5 Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 16

3.6 Electrophysiology Ablation Catheters – Ongoing Clinical Trials 17

4 Electrophysiology Ablation Catheters – Pipeline Products under Development by Companies 18

4.1 Electrophysiology Ablation Catheters Companies – Pipeline Products by Stage of Development 18

4.2 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 20

5 Electrophysiology Ablation Catheters Companies and Product Overview 22

5.1 Ablacon Inc Company Overview 22

5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Acotec Scientific Co Ltd Company Overview 23

5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Apama Medical Inc Company Overview 29

5.3.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.4 Biosense Webster Inc Company Overview 30

5.4.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 BioTex Inc Company Overview 36

5.5.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.6 Boston Scientific Corp Company Overview 37

5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 37

5.7 CardioFocus Inc Company Overview 44

5.7.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.8 CardioNova Ltd Company Overview 47

5.8.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.9 CathEffects LLC Company Overview 48

5.9.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.10 CathRx Ltd Company Overview 49

5.10.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.11 Cibiem Inc Company Overview 52

5.11.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.12 Columbia University Company Overview 55

5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 55

5.13 Cordis Corp Company Overview 56

5.13.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 56

5.14 CoreMap Inc Company Overview 57

5.14.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.15 CPSI Biotech Company Overview 58

5.15.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 58

5.16 CryoTherapeutics Gmbh Company Overview 59

5.16.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 59

5.17 Epicardial Technologies Inc (Inactive) Company Overview 62

5.17.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

5.18 Ethicon US LLC Company Overview 63

5.18.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 63

5.19 Eximo Medical Ltd Company Overview 64

5.19.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.20 FocusStart LLC Company Overview 65

5.20.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.21 Hansen Medical Inc (Inactive) Company Overview 66

5.21.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 66

5.22 Hyblate Medical Company Overview 67

5.22.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 67

5.23 Imricor Medical Systems Inc Company Overview 68

5.23.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.24 Interventional Imaging, Inc. Company Overview 69

5.24.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

5.25 Iowa Approach Inc. Company Overview 70

5.25.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 70

5.26 Maestro Heart SA Company Overview 72

5.26.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 72

5.27 Medlumics SL Company Overview 73

5.27.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 73

5.28 Medtronic Plc Company Overview 74

5.28.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 74

5.29 MedWaves Inc Company Overview 75

5.29.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.30 MicroPort Scientific Corp Company Overview 76

5.30.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 76

5.31 Northwestern University Company Overview 78

5.31.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 78

5.32 Novasentis Inc Company Overview 79

5.32.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.33 S4 Medical Corp Company Overview 80

5.33.1 S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 80

5.34 SCR, Inc. Company Overview 81

5.34.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

5.35 Seattle Children’s Hospital Company Overview 82

5.35.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 82

5.36 Shanghai HeartCare Medical Technology Co Ltd Company Overview 83

5.36.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

5.37 Shanghai MicroPort EP MedTech Co Ltd Company Overview 84

5.37.1 Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

5.38 St. Jude Medical LLC Company Overview 86

5.38.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 86

5.39 Stereotaxis Inc Company Overview 89

5.39.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.40 University of Arkansas at Little Rock Company Overview 91

5.40.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 91

5.41 University of Michigan Company Overview 92

5.41.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 92

5.42 University of Rochester Company Overview 93

5.42.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 93

5.43 University of Texas Medical Branch at Galveston Company Overview 94

5.43.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 94

5.44 Vanderbilt University Company Overview 95

5.44.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 95

5.45 Vimecon GmbH Company Overview 96

5.45.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 96

5.46 Vivonics Inc Company Overview 97

5.46.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 97

5.47 Voyage Medical (Inactive) Company Overview 98

5.47.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 98

5.48 Zylox-Tonbridge Medical Technology Co Ltd Company Overview 99

5.48.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

6 Electrophysiology Ablation Catheters- Recent Developments 100

6.1 Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China 100

6.2 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 100

6.3 Nov 02, 2021: Cordis Names Muscari President Of The Americas 101

6.4 Nov 01, 2021: Japan Lifeline Announces FY3/2022 2Q Financial Results 101

6.5 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021 101

6.6 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 102

6.7 Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center 106

6.8 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 107

6.9 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results 107

6.10 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D. 108

6.11 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021 108

6.12 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders 109

6.13 Jun 24, 2021: Peter Arduini named CEO of GE healthcare 110

6.14 May 24, 2021: Boston Scientific to Participate in Bernstein’s 37th Annual Strategic Decisions Conference 111

6.15 May 17, 2021: MicroPort Orthopedics holds joint workshop on joint surgery with China-Japan Friendship Hospital 111

6.16 Mar 16, 2021: CathVision adds US profile to its Board of Directors 112

6.17 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 112

6.18 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 113

6.19 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule 113

6.20 Feb 04, 2021: Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 113

6.21 Jan 07, 2021: MicroPort EP “Talents Program” holds first theoretical training to enhance arrhythmias treatment at primary hospitals 114

7 Appendix 115

7.1 Methodology 115

7.2 About GlobalData 118

7.3 Contact Us 118

List of Tables

Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 12

Electrophysiology Ablation Catheters – Pipeline Products by Segment 13

Electrophysiology Ablation Catheters – Pipeline Products by Territory 14

Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 15

Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 16

Electrophysiology Ablation Catheters – Ongoing Clinical Trials 17

Electrophysiology Ablation Catheters Companies – Pipeline Products by Stage of Development 18

Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 20

Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Ablasense – Product Status 22

Ablasense – Product Description 22

Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

ERA-C30 Endovenous Radiofrequency Closure Catheter – Product Status 23

ERA-C30 Endovenous Radiofrequency Closure Catheter – Product Description 23

ERA-C70 Endovenous Radiofrequency Closure Catheter – Product Status 24

ERA-C70 Endovenous Radiofrequency Closure Catheter – Product Description 24

ERA-G5 Endovenous Radiofrequency Closure Generator – Product Status 24

ERA-G5 Endovenous Radiofrequency Closure Generator – Product Description 25

Acotec Scientific Co Ltd – Ongoing Clinical Trials Overview 26

ERA-C70 Endovenous Radiofrequency Closure Catheter – Endovenous Radiofrequency Closure Catheter and Endovenous Radiofrequency Closure Generator in the Treatment of Varicose Veins of Lower Extremity 27

ERA-C30 Endovenous Radiofrequency Closure Catheter – Endovenous Radiofrequency Closure Catheter and Endovenous Radiofrequency Closure Generator in the Treatment of Varicose Veins of Lower Extremity 28

Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 29

LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Status 29

LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Description 29

Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 30

CARTO SMARTTOUCH 5D Catheter – Product Status 30

CARTO SMARTTOUCH 5D Catheter – Product Description 30

Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter – Product Status 31

Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter – Product Description 31

THERMOCOOL SMARTTOUCH SF-5D Catheter – Product Status 31

THERMOCOOL SMARTTOUCH SF-5D Catheter – Product Description 32

Biosense Webster Inc – Ongoing Clinical Trials Overview 33

Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter – Safety and Effectiveness Evaluation of the Multi-electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation: STELLAR 34

THERMOCOOL SMARTTOUCH SF-5D Catheter – Acute Performance Evaluation of the QDOT Micro Catheter Used with nGEN Generator in Treatment of Patients with Atrial Fibrillation 35

THERMOCOOL SMARTTOUCH SF-5D Catheter – Evaluation of QDOT Micro Catheter for Pulmonary Vein Isolation (PVI) in Subjects with PAF 35

THERMOCOOL SMARTTOUCH SF-5D Catheter – Evaluation of the Safety and Performance of the Very High Power-short Duration QDOT Strategy in Patients Referred for Atrial Fibrillation Ablation 35

BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Cooled Tip Catheter – Product Status 36

Cooled Tip Catheter – Product Description 36

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 37

Intellanav Stablepoint – Product Status 37

Intellanav Stablepoint – Product Description 38

Next Generation Blazer Catheter – Product Status 38

Next Generation Blazer Catheter – Product Description 38

Next Generation IntellaTip Catheter – Product Status 39

Next Generation IntellaTip Catheter – Product Description 39

Polarx Next Generation Catheter – Product Status 39

Polarx Next Generation Catheter – Product Description 40

POLARx Single Shot Cryoballoon – Product Status 40

POLARx Single Shot Cryoballoon – Product Description 40

Boston Scientific Corp – Ongoing Clinical Trials Overview 41

Intellanav Stablepoint – Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation 42

Intellanav Stablepoint – Electrical Coupling Information from the Rhythmia HDx Mapping System and Directsense Technology in the Treatment of Paroxysmal Atrial Fibrillation: A Non-randomized Prospective Study with Contact Force 42

POLARx Single Shot Cryoballoon – Comparison of the PolarX and the Arctic Front Cryoballoon for Pulmonary Vein Isolation in Patients with Symptomatic Paroxysmal Atrial Fibrillation – A Multi-center Non-inferiority Design Clinical Trial 43

POLARx Single Shot Cryoballoon – POLARx Cardiac Cryoablation System Post Market Clinical Follow-up Study 43

POLARx Single Shot Cryoballoon – Safety and Effectiveness IDE Trial for Boston Scientific’s Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation 43

CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 44

HeartLight X3 System – Product Status 44

HeartLight X3 System – Product Description 44

CardioFocus Inc – Ongoing Clinical Trials Overview 45

HeartLight X3 System – A Prospective Multicenter U.S. Comparison of Radiofrequency, Cryoballoon and Laser Balloon Modalities for Pulmonary Vein Isolation Ablation in Patients with Atrial Fibrillation 46

CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Electrophysiology Catheter – Atrial Fibrillation – Product Status 47

Electrophysiology Catheter – Atrial Fibrillation – Product Description 47

CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Desai VectorCathRF1 Mapping And Ablation Catheter – Product Status 48

Desai VectorCathRF1 Mapping And Ablation Catheter – Product Description 48

CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

CathRx 4mm Therapeutic Catheter – Product Status 49

CathRx 4mm Therapeutic Catheter – Product Description 49

CathRx 8mm Therapeutic Catheter – Product Status 50

CathRx 8mm Therapeutic Catheter – Product Description 50

Khelix Irrigated Ablation EP Catheter – Product Status 50

Khelix Irrigated Ablation EP Catheter – Product Description 51

Khelix Non-Irrigated Ablation EP Catheter – Product Status 51

Khelix Non-Irrigated Ablation EP Catheter – Product Description 51

Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Catheter-Based Carotid Body Ablation System – Product Status 52

Catheter-Based Carotid Body Ablation System – Product Description 52

Cibiem Inc – Ongoing Clinical Trials Overview 53

Catheter-Based Carotid Body Ablation System – First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study 54

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 55

Optically-Integrated RFA Catheter – Product Status 55

Optically-Integrated RFA Catheter – Product Description 55

Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 56

EP Contact Force Sensing Catheter Enabled By CARTO 3 – Product Status 56

EP Contact Force Sensing Catheter Enabled By CARTO 3 – Product Description 56

CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Electrophysiology Mapping System – Atrial Fibrillation – Product Status 57

Electrophysiology Mapping System – Atrial Fibrillation – Product Description 57

CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 58

FrostBite – Product Status 58

FrostBite – Product Description 58

CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 59

Cryotherapy System – Coronary Artery Disease – Product Status 59

Cryotherapy System – Coronary Artery Disease – Product Description 59

CryoTherapeutics Gmbh – Ongoing Clinical Trials Overview 60

Cryotherapy System – Coronary Artery Disease – Intracoronary Cryotherapy Effect for Stabilization of Vulnerable Plaque at Risk of Rupture as Assessed by imaging 61

Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

Epicardial Access Device – Product Status 62

Epicardial Access Device – Product Description 62

Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 63

Next Generation Ablation Catheter – Product Status 63

Next Generation Ablation Catheter – Product Description 63

Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

AURYON Atherectomy System – CAD – Product Status 64

AURYON Atherectomy System – CAD – Product Description 64

FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 65

Anti-coagulum Cardiac Ablation Catheter – Product Status 65

Anti-coagulum Cardiac Ablation Catheter – Product Description 65

Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 66

Sensei X Robotic Catheter System – Atrial Fibrillation – Product Status 66

Sensei X Robotic Catheter System – Atrial Fibrillation – Product Description 66

Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 67

Hybrid Ablation Catheter – Product Status 67

Hybrid Ablation Catheter – Product Description 67

Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Vision MR Ablation Catheter – Product Status 68

Vision MR Ablation Catheter – Product Description 68

Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

Atrial Fibrillation Catheter – Product Status 69

Atrial Fibrillation Catheter – Product Description 69

Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 70

MaPP-CS – Product Status 70

MaPP-CS – Product Description 70

ROF-AC – Product Status 71

ROF-AC – Product Description 71

ROF-AS – Product Status 71

ROF-AS – Product Description 71

Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 72

Maestro-AF Catheter System – Product Status 72

Maestro-AF Catheter System – Product Description 72

Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 73

AblaView – Product Status 73

AblaView – Product Description 73

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 74

Osteocool 2.0 – Product Status 74

Osteocool 2.0 – Product Description 74

MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 75

Arrhythmia Catheters – Product Status 75

Arrhythmia Catheters – Product Description 75

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 76

Circular Ablation Catheter – Product Status 76

Circular Ablation Catheter – Product Description 76

Voyager Irrigated RF Ablation Catheter – Product Status 77

Voyager Irrigated RF Ablation Catheter – Product Description 77

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 78

Cardiac Catheter – Product Status 78

Cardiac Catheter – Product Description 78

Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Electroactive Polymer Based Steerable Catheter – Product Status 79

Electroactive Polymer Based Steerable Catheter – Product Description 79

S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 80

esolution Device – Product Status 80

esolution Device – Product Description 80

SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

Atrial Fibrillation Device – Product Status 81

Atrial Fibrillation Device – Product Description 81

Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 82

Ablation Catheter – Heart Arrhythmia – Product Status 82

Ablation Catheter – Heart Arrhythmia – Product Description 82

Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

Cryoablation Catheter – Product Status 83

Cryoablation Catheter – Product Description 83

Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

FireMagic TT 3D Ablation Catheter – Product Status 84

FireMagic TT 3D Ablation Catheter – Product Description 84

IceMagic Cryoablation Catheter – Product Status 85

IceMagic Cryoablation Catheter – Product Description 85

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 86

FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Status 86

FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Description 86

St. Jude Medical LLC – Ongoing Clinical Trials Overview 87

FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Flexability Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study 88

Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Magnetic Ablation Catheter – Product Status 89

Magnetic Ablation Catheter – Product Description 89

Next Generation Irrigated Magnetic Catheter – Product Status 90

Next Generation Irrigated Magnetic Catheter – Product Description 90

University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 91

Robotic Catheter – Product Status 91

Robotic Catheter – Product Description 91

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 92

Non-Contact Mapping Catheter – Product Status 92

Non-Contact Mapping Catheter – Product Description 92

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 93

RF Ablation Catheter – Product Status 93

RF Ablation Catheter – Product Description 93

University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 94

Ablation Catheter – Product Status 94

Ablation Catheter – Product Description 94

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 95

Temperature Controlled Catheter – Product Status 95

Temperature Controlled Catheter – Product Description 95

Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 96

Vimecon Laser CAI Catheter – Product Status 96

Vimecon Laser CAI Catheter – Product Description 96

Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 97

Catheter Guidance System – Product Status 97

Catheter Guidance System – Product Description 97

Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 98

IRIS Ablation System – Product Status 98

IRIS Ablation System – Product Description 98

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

Endovenous Radiofrequency Ablation Catheter – Product Status 99

Endovenous Radiofrequency Ablation Catheter – Product Description 99

List of Figures

Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 13

Electrophysiology Ablation Catheters – Pipeline Products by Segment 14

Electrophysiology Ablation Catheters – Pipeline Products by Territory 15

Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 16

Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 17

Frequently Asked Questions

The key territories in the electrophysiology ablation catheters pipeline products market are the US, China, Europe, Israel, Australia, Japan, Macau, New Zealand, and Hong Kong.

The key segments in the electrophysiology ablation catheters pipeline products markets are irrigated tip RF ablation catheters, conventional radio frequency ablation catheters, cryoablation catheters, advanced ablation catheters, laser ablation catheters, and standard ablation catheters.

The key companies in the electrophysiology ablation catheters pipeline products market are Ablacon Inc, Acotec Scientific Co Ltd, Apama Medical Inc, APT Medical Inc, Biosense Webster Inc, BioTex Inc, Boston Scientific Corp, CardioFocus Inc, CardioNova Ltd, CathEffects LLC, CathRx Ltd, Cibiem Inc., Columbia University, Cordis Corp, and CoreMap Inc

$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods